<DOC>
	<DOCNO>NCT01225042</DOCNO>
	<brief_summary>Background : The incidence gastrointestinal infection high . In European country 10-25 % population suffers least one foodborne infection per year . Probiotics may strengthen human resistance gut infection may beneficially modulate intestinal microbiota composition activity , immune function upon intestinal infection . Aim : To study whether probiotic improve resistance human enterotoxigenic E. coli ( ETEC ) . Study design : The PRETEC study parallel , double-blind , placebo-controled 4-weeks intervention probiotic healthy volunteer . In study , effect probiotic intervention v placebo several infection marker response ETEC challenge investigate . Participants randomly assign probiotic placebo group ( n=21 per group ) . Subjects instruct maintain habitual food intake , standardize dietary calcium intake . After adaptation period 2 week , subject orally infected live , attenuate , ETEC vaccine ( strain E1392-75-2A ; collection NIZO food research ; dose 10E10 CFU ) . This ETEC strain induces mild short-lived infectious diarrhea symptom . Before infection , diary keep write food drink consumption ( 2x2 day ) assess habitual dietary intake . The diary also use daily record bowel habit frequency severity gastrointestinal complaint . Blood sample immune response analyse multiple faecal sample collect quantify several infection- immune system marker , determine probiotic excretion , verify dietary calcium intake . Study population : Healthy male 20-55 yrs age . Interventions : Probiotics ( freeze-dried powder , dose 10E9 CFU twice daily ) placebo ( carrier material powder identical appearance ) . Primary outcome : Total fecal ETEC excretion per day severity diarrhea ( quantified faecal output per day ) . Secondary outcome : Serum immune response ETEC , self-reported stool consistency score gastrointestinal complaint , relative faecal wet weight , sIgA calprotectin faeces , probiotic persistence level opportunistic pathogen endogenous microbiota .</brief_summary>
	<brief_title>The Effect Probiotics E. Coli Gastroenteritis</brief_title>
	<detailed_description>The timeframes analysis primary secondary outcome mention Outcome Measures section .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gastroenteritis</mesh_term>
	<criteria>Signed informed consent Male Age 2055 yr Willingness replace habitual dairy product intake supplied low calcium soy milk product Willingness abstain product high amount prebiotic fiber product probiotic ( except supply one ) Current previous underlie disease GI tract lactose intolerance Use antibiotic , norit , laxatives , cholestyramine , acid burn inhibitor , immune suppressiva , prebiotics , probiotic detectable serum antibody ETEC carriage streptomycinresistant E. coli faeces ( relevant culturing technique ETEC apply instead specific RTPCR ) vegetarians heavy alcohol use drug use</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>infectious diarrhea</keyword>
	<keyword>probiotic</keyword>
	<keyword>prevention</keyword>
	<keyword>dietary intervention</keyword>
	<keyword>E. coli infection</keyword>
	<keyword>intestinal infection</keyword>
	<keyword>intestinal resistance</keyword>
</DOC>